KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Goodwill: 2018-2025

Historic Goodwill for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $82.2 million.

  • Twist Bioscience's Goodwill fell 4.21% to $82.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.2 million, marking a year-over-year decrease of 4.21%. This contributed to the annual value of $82.2 million for FY2025, which is 4.21% down from last year.
  • As of Q3 2025, Twist Bioscience's Goodwill stood at $82.2 million, which was down 0.00% from $82.2 million recorded in Q2 2025.
  • Twist Bioscience's 5-year Goodwill high stood at $85.8 million for Q2 2022, and its period low was $1.1 million during Q1 2021.
  • Over the past 3 years, Twist Bioscience's median Goodwill value was $85.8 million (recorded in 2025), while the average stood at $85.2 million.
  • Its Goodwill has fluctuated over the past 5 years, first soared by 7,428.82% in 2022, then dropped by 4.21% in 2025.
  • Over the past 5 years, Twist Bioscience's Goodwill (Quarterly) stood at $84.2 million in 2021, then rose by 1.86% to $85.8 million in 2022, then remained steady at $85.8 million in 2023, then remained steady at $85.8 million in 2024, then declined by 4.21% to $82.2 million in 2025.
  • Its last three reported values are $82.2 million in Q3 2025, $82.2 million for Q2 2025, and $85.8 million during Q1 2025.